Saturday, February 2, 2013

It's My Birthday! | Fashionably Living

I love Birthday?s! ?My mom always made such a big deal out of my birthday growing up, that now I look forward to my special day every year! ?She always made me feel so special and now she has passed that torch onto my husband! ?I started my morning in bed with a cup of coffee, while skimming the pages of Travel and Leisure while I waited on breakfast in bed! ?My husband never makes me coffee, but I swear he secretly watches me make it everyday, because the coffee was so good! ? My mom came and made be breakfast in bed and my husband and I lounged in bed eating ?and talking. ?Last year, my husband had to work on my birthday, but he dropped off flowers at my work and then told me to be at the spa by noon and he had scheduled me a massage and pedicure! ?This year I am lucky enough to spend the entire day with him! ?We plan to go to lunch with my family and then he is taking me shopping! YEAH!!! ?Last year, he took me shopping the day after my birthday and I had way too much fun in Forever 21! ?Well, its that time of year again?here?s to birthday shopping round 2! Cheers!

XO,

Rachel Ashley

Source: http://fashionablyliving.com/its-my-birthday/

guy fawkes gary johnson gary johnson walking dead where do i vote dixville notch Remember Remember The 5th Of November

In Capable Hands: Profiling the New Leadership at the PTO ...

USPTO Senior Leadership. From left to right: Acting Director Teresa Rea, Trademarks Commissioner Deborah Cohn, and Patent Commissioner Peggy Focarino. Taken by Renee Quinn at the Women?s Symposium at the USPTO.

Today is the last day of the Kappos era at the United States Patent and Trademark Office. Director Kappos assumed control of the Office in August 2009, and three and one-half years later he is leaving the Office a better place, with virtually all metrics pointing in the right direction. The backlog of applications is down, the backlog of appeals has started to fall, the most sweeping patent reform in generations has passed, the USPTO has promulgated volumes of new rules to make the patent system better and to implement the America Invents Act, there has been a Memorandum of Agreement signed with the Smithsonian on the Innovation Expo, which will be held in June 2013, and the future Innovation Pavilion that will be housed at the Arts and Industries building, a new examiner count system was put in place revising the production goals and time given to examiners for the first time in more than a generation, the patent bar examination was updated for the first time in 5? years and continues to be updated every six months. The accomplishments are many. These are but a few that leap to mind at the moment.

But how will the Patent Office fare when the clock strikes 12:00 midnight later tonight and Director Kappos becomes private citizen Kappos? The USPTO will be in very capable hands. One of the biggest accomplishments of the Kappos Administration happened behind the scenes but oddly in plain view. I speak of ?Team Kappos? regularly. It is because they are a team in a very real sense as far as I can tell. And while the assembly of the team was done in the public eye and those interested enough know who Kappos? top lieutenants have been, Kappos quitely assembled an extremely talented team of dedicated, hard working individuals who will capably carry on.

Before profiling the top officials who will continue the work of the patent system, allow me also to pause and recognize a truly extraordinary moment in Patent Office History. The top three officials at the USPTO will all be women. Acting Director Teresa Rea, Commissioner for Patents Peggy Focarino and Commissioner for Trademarks Deborah Cohn will lead the Office forward steering America?s engine of innovation and commerce. If that doesn?t create a buzz of excitement even in Washington, DC, I don?t know what will! It is excitement well deserved and perhaps could lead to a higher profile for the USPTO, which would be very good for the patent system as a whole.

?

Then USPTO Deputy Director, Teresa Rea in her office on January 17, 2012.

Teresa Stanek Rea, Acting Director
United States Patent and Trademark Office

In December 2011, after I concluded an interview with Director Kappos I asked him to give me some thoughts on his Senior Management Team, in anticipation of interviewing members of that team as a part of our USPTO 2.0 series. ?When I say ?Teresa Rea? what are the first things that come to mind,? I asked. Kappos responded: ?Tremendous background knowledge, energy, fun person to work with and to team with, deep knowledge of the life sciences sector?? Director Kappos would go on to say that with Rea at the agency ?we?ve got all the bases covered. I?m the corporate guy, she?s the litigator. I?m the IT guy, she?s the Pharma person.? Indeed, Teresa Rea is the real deal. For several years she has been the near perfect compliment to Director Kappos, providing biotech and pharma knowledge to compliment Kappos? IT expertise.

Rea is also no stranger to the intellectual property world. She is a former President of the American Intellectual Property Law Association (AIPLA), and a long time patent practitioner, having been admitted to the patent bar on December 15, 1981. Prior to joining the USPTO, Rea?s practice focused on complex patent litigation and inter partes matters, as well as patent procurement and portfolio management, including patent preparation and prosecution. Rea also has experience in drafting infringement and validity opinions, as well as interference, and licensing matters.

Rea at a swearing in ceremony for new PTAB judges, March 1, 2012.

One of the things that makes her particularly well suited for the job of Acting Director is that the biggest issues facing the patent system at the moment are in the life sciences and biotechnology sector ? think Prometheus and Myriad Technologies, for example. The Supreme Court will her Myriad this term and issue its decision by the end of June 2013. Having someone in the lead chair intimately familiar with the realities of practice and the workings of government will serve the Office well as guidance is given to patent examiners.

I have had the opportunity to interview Acting Director Rea twice.? See January 2012 interivew and February 2011 interview. In those interviews I found her to be extremely knowledgeable, indeed a real patent geek. A geek in a good way, of course. Patent professionals know what I mean. Many of us enjoy what we do, but infrequently get to talk to anyone about it who cares, so when we do the conversation is a blast. She is one of us. She has represented clients before the USPTO and in litigation, she has represented the industry as part of the AIPLA, and she has worked side-by-side in partnership with Director Kappos for two years. The Patent Office has been left in capable hands.

?

Commissioner Focarino in her office at the USPTO on January 27, 2012.

Peggy Focarino, Commissioner for Patents
United States Patent and Trademark Office

Margaret A. (Peggy) Focarino has been a long time employee of the United States Patent and Trademark Office, first starting with the USPTO in 1977 as a Patent Examiner.? She became a Supervisory Patent Examiner in 1989 and was promoted to the Senior Executive Service in 1997.? In January 2005, Focarino was promoted to Deputy Commissioner for Patent Operations, a role that made her responsible for all patent-examining functions in the eight Patent Technology Centers and all operational aspects of patent application initial examination, patent publications, and international Patent Cooperation Treaty (PCT) applications processing.? Upon the resignation of Jon Dudas from the USPTO in January 2009, then Commissioner for Patents John Doll rose from his post as Commissioner for Patents to become the Acting Director of the Patent Office.? At this time Focarino was promoted to Acting Commissioner for Patents. Upon Director Kappos assuming control of the Patent Office, Focarino was retained on the senior management team, with the creation of a new position ? Deputy Commissioner for Patents. Subsequently, after Commissioner Stoll retired, Focarino was promoted, this time being appointed Commissioner for Patents.

When I interviewed USPTO Director David Kappos in December I asked him about Focarino and the first words out of his mouth were: ?What a wonderful leader.?? Kappos went on to tell me:

Peggy?s the perfect next Commissioner for Patents. She?s got deep knowledge of the agency, extremely well respected in the IP community, rose up through the ranks, knows everything about patents and patent law and patent examination and works extraordinarily well with employees. She?s loved and she?s revered by the employees, not just respected. And if that weren?t enough, works terrifically well with the union. So Peggy?s the perfect package. She?s got tremendous judgment. She knows how to deal with people, she knows how to deal with issues, she?s very diplomatic and just a wonderful leader. I?ve been doing leadership for a long time. I?ve worked with and studied under some of the best leaders in the world and I know a good leader when I see one and Peggy is certainly one.

This lofty praise is consistent with what I have heard about Focarino many times over the years.? Indeed, I have only heard positive things about Focarino, and everyone expresses that she is not only a very nice person but a knowledgeable and respected leader within the Office.

Commissioner Focarino speaks at the USPTO

One particular story deserves mention. When Director Kappos set out to attempt to revamp the examiner count system there needed to be hard work done with the union to negotiate. The union was a willing partner, but no negotiations over work responsibilities are ever easy. Kappos put Focarino in charge of working with the union in her role as Deputy Commissioner at the time. What could have taken 6 months to a year was negotiated in 6 weeks. A new examiner count system gave examiners more time to work on cases, credit for engaging in interviews with attorneys and incentive to not constantly require RCEs. While the Office still has some issues with RCEs, the new examiner count system was the first rework in at least a generation and was an important step forward. It simply could not have been negotiated with such speed but for the hard work of Focarino, the willing participation of the union and a trust built up over years between the two. Simply said, in my opinion Commissioner Focarino is the right person for the job. She knows the Office top to bottom and is a hard working doer who leads by example.

I have also interviewed Focarino several times. See May 2009 interview and January 2012 interview.

?

Commissioner for Trademarks Deborah Cohn

Deborah Cohn,Commissioner for Trademarks
United States Patent and Trademark Office

Deborah Cohn is the Commissioner for Trademarks at the United States Patent and Trademark Office. Cohn oversees all aspects of the USPTO?s Trademarks organization including policy, operations and budget relating to trademark examination, registration and maintenance.

Commissioner Cohn joined the USPTO in 1983 as a trademark examining attorney and rose through the ranks to managing attorney and group director before becoming Deputy Commissioner for Trademark Operations in 2006. She also served as Acting Chief Administrative Officer for the agency from October 2007 to April 2008 and from May to September 2010.

While I know Commissioner Cohn, she is the member of the management team that I know least well. There is a saying about knowing more and more about less and less until you know everything about nothing. Well, over the years I have continued to focus on patent law to the expense of other areas of intellectual property law. I know what trademarks are, I know how important they are, and IPWatchdog is trademarked. A trademark expert, however, I am not. Thus, when I interviewed Commissioner Cohn I reached out to two attorneys at my firm who do a significant amount of trademark work ? Mark Malek and Mark F. Warzecha ? to ask for suggested questions for Commissioner Cohn. Commissioner Cohn was gracious and tolerant of this patent attorney slash blogger-journalist, and I believe our conversation was a good read.

What I can say specifically about Commissioner Cohn is that she overseas a finely tuned machine, which is the Trademarks operation at the USPTO. There are rarely, if ever, any problems with the Trademark operation. Indeed, no news is good news and the fact that Cohn has Trademarks running so smoothly is a blessing that will allow others on the team to focus on other issues that need attention.

Cohn has been at the helm for some time now and hopefully she will remain. As long as Cohn is running Trademarks Acting Director Rea will have no problems, and neither will whoever is the next Director. To explain it like an engineer ? Trademarks isn?t broken, so don?t fix it, just let it be and let Commissioner Cohn and her capable team continue their work.

?

Peter Pappas at a White House awards ceremony November 2010.

Peter Pappas, Chief of Staff
United States Patent and Trademark Office

On November 10, 2011, Peter Pappas became Chief of Staff to Director Kappos. Pappas, however, had been at the USPTO since early on in the Kappos Administration, serving as Chief Communications Officer initially. Even in the role of Chief Communications Office Pappas was one of the highest ranking lieutenants on Team Kappos. Pappas has a long list of government service as an attorney and political adviser. He has served as a liaison between the USPTO and the rest of the federal government. While that may not seem like an important role to some, Pappas? role has been critical. Coordination with the Department of Commerce has been what has allowed the Patent Office to accomplish so much.

Once upon a time Pappas served in the Clinton White House as an Assistant Counsel to the President. After leaving the White House Pappas became Director of Communications for Economic Affairs at the State Department. Subsequently, Pappas was tapped to become Associate Chief of the Federal Communication Commission?s International Bureau, overseeing international telecommunications policy in several areas, and being principally in charge of the Bureau?s Congressional and media relations. Immediately prior to his appointment at the USPTO, Pappas served an Executive Vice President for Legal and Government Affairs at Pappas Telecasting Companies, which was at the time the nation?s largest privately held commercial television station group with 27 affiliates in 15 markets nationwide. In that role, he managed the legal and regulatory affairs of the Company and served as its primary spokesperson.

Pappas (left) with Kappos (right) in Kappos? office at the U.S. Patent and Trademark Office, July 2010.

Early on in President Obama?s Administration it was clear that his Department of Commerce viewed the USPTO as a crown jewel. Even President Obama has mentioned patents and the Patent Office in more than one speech, something of a Presidential record if not an outright shocker. In fact, President Obama gave one entire speech on the need for the USPTO to have state of the art computers and IT systems. Certainly President Obama deserves credit, but it is also important to recognize those at the Patent Office who are familiar with government and how it operates. That allows any agency more ability to affect positive change. Pappas has been an important player on Team Kappos.

Pappas will remain at the USPTO even after Kappos departs. It is expected he will continue on in the same capacity. I have heard idle speculation by some that his influence may diminish once Kappos leaves. I find that entirely unlikely. If possible, he will likely become an even more important player. While Acting Director Rea has all the industry experience anyone could ever ask for in a Director, she doesn?t have an excessive amount of experience on Capitol Hill. Working with AIPLA she has testified before Congress, but the primary job of the Deputy Director under the Kappos Administration was not testifying or making rounds on Capitol Hill. Thus, having someone as politically savvy as Pappas on the team will be good for Rea, which means it will be good for the Patent Office and the patent system generally.

Like all of the most senior members of Team Kappos, I have interviewed Pappas. See Exclusive Intervoew: USPTO Chief of Staff Peter Pappas.

?

USPTO General Counsel Bernard Knight (left) and USPTO Solicitor Raymond Chen (right)

Bernard Knight, General Counsel
Ray Chen, Solicitor
United States Patent and Trademark Office

Bernie Knight and Ray Chen, the top two attorneys who represent the United States government at the U.S. Patent and Trademark Office.

Knight is the General Counsel at the USPTO, and Chen is the Solicitor. ?I have known each for a few years now, and I can?t tell you how many times I have asked them to go on the record for an interview. I finally convinced them to be interviewed jointly in August 2012.

Knight started his career as a tax lawyer at a large Houston, Texas, based law firm. From there he went to the Justice Department as a litigator trying tax cases.? Subsequently, while Todd Dickinson was Director, Knight was hired to be the first Deputy General Counsel of the USPTO. Knight then left the USPTO for a time.? He applied for a job at the Treasury Department, to be a Deputy Assistant General Counsel.? That job went to an internal candidate, but Knight impressed folks at Treasury and was offered a more senior position as Assistant General Counsel for General Law, Ethics, Litigation, and Regulations.? Then at the end of the Bush Administration Secretary Paulson had to pick one of the senior lawyers to be the Acting General Counsel of the Treasury Department until a new General Counsel could be selected by President Obama and confirmed by the Senate.? Secretary Paulson picked Knight.? He was Acting General Counsel at Treasury for the first about eight months of the Obama Administration.?? Newly confirmed Director Kappos asked Knight if he would like to come back to the USPTO to be the General Counsel, the position he holds currently.

Chen is a hard core patent guy. He told me that when he left law school he knew he was going to be a patent attorney and never leave California. But love got in the way. His girlfriend, now wife, took a job in Washington, DC. The prompted Chen to seek employment in the DC area. He applied to the Federal Circuit for? a staff attorney position, which he obtained. He noticed that there were young lawyers from the USPTO advocating appeals before the CAFC and that was what he ultimately wanted to do. So he applied for a job in the Solicitor?s Office at the USPTO and the rest is history. Chen rose through the ranks to become Solicitor, the man in charge of USPTO arguments and appeals. Chen knows patent law as well as anyone I know, and I have heard rumors that he is being vetted for possible appointment to the Federal Circuit. He would make an excellent judge on the Federal Circuit, but in the meantime the USPTO has a real superstar Solicitor.

?

Patent Trial and Appeals Board: Chief Judge James Smith (left) and Vice-Chief Judge James Moore (right). November 28, 2012.

Chief Judge James Smith
Vice-Chief Judge James Moore
PTAB, United States Patent and Trademark Office

Chief Judge James Moore and Vice-Chief Judge James Smith are the top two Administrative Patent Judges at the United States Patent and Trademark Office. I had the honor of interviewing them together in an interview published on January 1, 2013.

The PTAB was newly created on September 16, 2012, to replace the Board of Patent Appeals and Interferences. The name has changed to take into account the new workload on so-called post-grant procedures ushered in by Phase II of the America Invents Act, which went into effect on September 16, 2012. The Board, however, is still the Board, and Smith and Moore have been at the helm in charge of unprecedented growth in the number of Judges.

I have known both Smith and Moore for some time and have the utmost respect for both men. I continue to hear rumors that Chief Judge Smith may be in line for consideration for an appointment to the Federal Circuit, which speaks volumes about his ability but also what those in high places think of him and his work. Could we see Smith on the Federal Circuit soon and Vice-Chief Moore become Chief? I wouldn?t doubt it one bit. Both men are talented administrators who I suspect have great things to contribute to the USPTO and the patent system generally.

?

The Rest of the Team

I have focused my attention so far on those I have interviewed and know the best. There are, however, several other key players that deserve to be mentioned. For example, John Owens is the Chief Information Office and he and his team are overseeing an enormous update to the USPTO IT systems. The crown jewel will be Patents End2End, which I have seen unveiled in prototype at a public meeting at the USPTO. This is going to revolutionize how examiners work, making them more productive. That will allow them to do tasks more quickly, but the plan will not be to ask examiners to do more applications. Thus the productivity savings will translate into more time to examine, which will lead to higher quality patents.

Still another that could be mentioned is Shira Perlmutter, Chief Policy Officer and Director for International Affairs, whom I am scheduled to interview soon. Prior to joining the USPTO Perlmutter was Executive Vice President for Global Legal Policy at the International Federation of the Phonographic Industry (IFPI). Prior to that, she held the position of Vice President and Associate General Counsel for Intellectual Property Policy at Time Warner.

Still further, Todd Elmer, Chief Communications Officer, is an attorney who spent time working as an international trade attorney at the U.S. Department of Commerce and in the Washington, D.C. office of Kaye Scholer. He has also served as a member of White House advance teams for President Clinton and Vice President Gore, and served in a variety of leadership capacities in the 2000, 2004, and 2008 Democratic presidential campaigns.

?

Conclusion

As a Republican it pains me in some ways to say it, but President Obama?s election has been objectively positive for the United States Patent and Trademark Office. I don?t know that the innovation industry could have survived had the leadership of the USPTO during the Bush years been extended any further. But long gone are those days and over the last 3+ years Director Kappos has not only accomplished much, but he has put in place a team of highly capable, very experienced individuals.

The legacy of a leader is what will happen after the leader is gone. Perhaps it is not surprising that Kappos, who spent his entire career at IBM prior to joining the USPTO, has left the Office with such a strong leadership team in place. The way that IBM succeeds is by growing leaders from within who understand the culture and are dedicated to the company, occasionally hiring highly qualified outsiders to bring in fresh new ideas. That approach has served Kappos well, and it leaves us all in a very good place. I am optimistic about the future.

Copyright?protected?by?Digiprove???2013

Source: http://www.ipwatchdog.com/2013/01/31/in-capable-hands-profiling-the-new-leadership-at-the-pto/id=34464/

rajon rondo brazil usps Dick Van Dyke anne hathaway pro bowl victoria azarenka

Friday, February 1, 2013

Two-step immunotherapy attacks advanced ovarian cancer

Jan. 31, 2013 ? Most ovarian cancer patients are diagnosed with late stage disease that is unresponsive to existing therapies. In a new study, researchers from the Perelman School of Medicine at the University of Pennsylvania School of Medicine show that a two-step personalized immunotherapy treatment -- a dendritic cell vaccine using patients' own tumor followed by adoptive T cell therapy -- triggers anti-tumor immune responses in these type of patients. Four of the six patients treated in the trial responded to the therapy, the investigators report this month in OncoImmunology.

"What we proved in this study is that this is a safe treatment strategy," says co-first author Lana Kandalaft, PharmD, MTR, PhD, research assistant professor of Obstetrics and Gynecology and director of clinical development in the Ovarian Cancer Research Center. "It is a walk in the park for patients, especially compared to standard chemotherapies and surgical treatments for ovarian cancer -- literally, some patients left the clinic and went for a walk in a nearby park after their treatment."

The findings follow research by the study's senior author, George Coukos, MD, PhD, director of the Ovarian Cancer Research Center at Penn, who showed in 2003 that women whose ovarian tumors were infiltrated by healthy immune cells, called T cells, tended to live longer than women whose tumors were devoid of T cells. That observation and other subsequent ones suggest the patient's immune system is trying to fight off the disease but can't quite muster the strength to beat it. Therefore, investigators have been trying to find ways using patients' own tumor cells to boost the immune system's power.

In the current study, Coukos, Kandalaft, co-first author Daniel J. Powell Jr., PhD, research assistant professor of Pathology and Laboratory Medicine, and colleagues treated six women with advanced ovarian cancer in a two-staged immunotherapy protocol in which they utilized a dendritic cell vaccine created from tissue in the patients' own tumor, which was stored at time of surgery. All of these women's cancers had progressed on standard of care chemotherapy.

In the first segment of the study, the team prepared an individualized dendritic cell vaccine for each patient. They harvested dendritic cells from each patient using apheresis, the same process volunteers go through when they donate platelets or other blood products such as those collected for stem cell transplants. Kandalaft and colleagues then exposed each patient's dendritic cells to tumor extract produced from the woman's own tumor, which teaches the dendritic cells who the enemy is. After this priming, the investigators vaccinated each patient with her own dendritic cells and gave them a combination chemotherapy regimen of bevacizumab and cyclophosphamide. Because dendritic cells are like the generals of the immune system, they then induce other immune cells to take up the fight.

Of the six patients who received the dendritic cell vaccine, four developed an anti-tumor immune response, indicating that the approach was working. One of those patients had no measurable disease at study entry because all of it had been successfully removed during surgery. She remains in remission today, 42 months following vaccine treatment. The other three who had an immune response to the vaccine still had residual disease and went on to the second segment of treatment.

The team harvested T cells from each of these three women. Using a technique developed at Penn, they grew the cells in the laboratory, expanding their numbers exponentially, and then reintroduced them into each patient after she underwent a lymphodepleting chemotherapy regimen. Because the T cells had already been trained by the dendritic cell vaccine to attack the tumor cells, the adoptive T cell transfer amplifies the anti-tumor immune response.

Two of the women showed a restored immune response after the T cell transfer. One of the women continued to have stable disease, whereas the other had a complete response to the therapy.

The researchers say it is too early to say whether this type of therapy will be effective in a large number of ovarian cancer patients, but the early results are promising. First, and foremost, she notes, the two-step approach appears safe and well tolerated by the patients. Additionally, the team saw a correlation in both treatment steps between immune responses and clinical benefit, suggesting that it is, in fact, the immune response that is holding the disease in check.

With these encouraging results in hand, the team has opened a larger trial in which they have already enrolled about 25 women and aim for up to 30 more. The new protocol uses an improved vaccine platform and an optimized adoptive T cell transfer protocol. The PI of this study is Janos Tanyi, MD, PhD.

"Large clinical trials have shown that intensifying chemotherapy doesn't improve outcomes for women with advanced ovarian cancer," Coukos says. "So we need to explore other avenues. We think the combinatorial approach of both immune and chemotherapy is the way to go."

Other co-authors from Penn include Cheryl L. Chiang, Janos Tanyi, Sarah Kim, Kathy Montone, Rosemarie Mick, Bruce L. Levine, Drew A. Torigian, and Carl H. June. Co-author Marnix Bosch is from Northwest Biotherapeutics in Bethesda, MD.

This study was supported by National Cancer Institute Ovarian SPORE grant P01-CA83638, National Institution of Health R01FD003520-02, and the Ovarian Cancer Immunotherapy Initiative.

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:


Story Source:

The above story is reprinted from materials provided by University of Pennsylvania School of Medicine.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.


Journal Reference:

  1. Lana E. Kandalaft, Daniel J. Powell, Cheryl L. Chiang, Janos Tanyi, Sarah Kim, Marnix Bosch, Kathy Montone, Rosemarie Mick, Bruce L. Levine, Drew A. Torigian, Carl H. June and George Coukos. Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancer. OncoImmunology, 2013; 2: e22664 [link]

Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.

Source: http://feeds.sciencedaily.com/~r/sciencedaily/top_news/~3/e4YY26wgzQU/130131163017.htm

the matrix oceans 11 ferris state hockey mary poppins john derbyshire kinkade thomas kinkade paintings

McCain: Immigration reform failure would cost GOP

WASHINGTON (AP) - In a warning to fellow Republicans, Sen. John McCain said Wednesday that failure to pass comprehensive immigration legislation could mean continued election losses for the GOP and cause Republican-friendly states like Arizona to fall to the Democrats.

The Arizona Republican, his party's former presidential nominee and one of eight senators to sign onto a bipartisan immigration reform framework this week, said failure to act means the trend of Hispanic defections from the GOP would continue.

Latino voters supported President Barack Obama over Republican Mitt Romney 71 percent to 27 percent in November, helping to ensure Obama's victory.

McCain said that Republicans have failed to understand the importance of immigration to Hispanic voters and that's cost the party at the ballot box.

"If you have a large bloc of Americans who believe you're trying to keep their ... fellow Hispanics down and deprive them of an opportunity, obviously that's going to have an effect," McCain said.

The Senate framework would provide a path to citizenship for the estimated 11 million illegal immigrants already in the country, secure the border, attempt to simplify legal immigration, and add requirements for employers to prevent hiring of illegal immigrants.

If no bill passes, McCain said, the forecast for Republicans is that "the trend will continue of lack of support from Hispanic voters, and also as you look at the demographics of states like mine that means that we will go from Republican to Democrat over time."

McCain spoke alongside Democratic Sen. Charles Schumer of New York, his partner on the immigration proposals, at a breakfast hosted by Politico.

Source: http://www.katu.com/news/national/-McCain-Immigration-reform-failure-would-cost-GOP-189018061.html

bob beckel anna paquin warren buffett 2012 nfl schedule dishonored april 18 delonte west

How do Banks Deal with Problem Loans ? Marine Money Ship ...

Commercial Banking Panel Session

This section addressed how banks dealt with problem loans, what is the level of bank activity at the moment, and advice for shipowners seeking loans.

Moderator: Robin Das,?Director Auld Partners Ltd.

Panel;

  • Mark Long, Head of Transport, Shipping Services and Offshore, HSBC Bank plc.
  • Thor Erling Kylstad, Head of Shipping, London Branch, Nordea Bank.
  • Nigel Anton, MD and Head of Shipping, Standard Chartered Bank.
  • Stephen Fewster, MD, Global Head, Shipping & Transportation Finance, ING Bank.
  • Alex Ryland, Senior VP, Shipping, Offshore & Logistics, DNB Bank ASA.

?Problem loans; what is the solution?

?The panel predictably said a solution was determined on a case-by-case basis and there wasn?t a one size fits all solution. If the owner has money and will put some more into the deal, the bank will try to match it, and maybe grant waivers (this is presumably with a client the bank wants to retain a relationship). Mr Fewster of ING said that they see the shipping industry as a ?mean reverting industry? and rates will swing back to the average and that they should give the owner time. (This, of course, depends on when the loan was granted and the average rates used in the loan repayment and cash flow projections). Other solutions include the sale of the loan to a hedge fund or another bank. One bank reported selling a bilateral loan in the secondary market for more than book value ? result! However, there is the remote danger that due to ?Chinese Walls? between the different parts of the bank, the loan could end up back in the bank, at a higher price!

?The panel admitted that syndicate banks are the major obstacle to achieving a solution (in a syndicated loan). The owner can pick up on this and play one bank against another. It depends on how the bank runs its problem loan book. Does the problem loan stay with the relationship manager, or is it taken away and dealt with by a special solutions group?

But most often it was a question of what is the level of trust between bank and bank and owner? Will the owner with money put more into the deal or are they being dishonest? Of course, the owner knows banks are very reluctant to takeover the ship and realise the loss. An arrest will mean the loss of oil major approval, so reducing the value of a tanker even further.

?Sometimes a loan is doomed, and the panel pointed to certain characteristics that have become evident during restructuring. One is a high chartered-in position with high operational leverage. The second is very high lending rates, for example ships bought at the peak of the market. Another characteristic highlighted by Mr Ryland of DNB is SOS ? small, old and specialised! This is where the bank tends to lose money (remember the fees generated are relatively small and writing off a loan can destroy the division profit for that

The panel felt that there will be more restructuring in 2013. The ships are getting older and the restructuring of a few years ago in the expectation of a market upturn may no longer be commercially viable. The so-called ?Zombie? companies as Lloyd?s List (David Osler) put it are being supported because the banks do not want to arrest the vessels.

?Going forward several of the banks on the panel expect to do new business in 2013, and have mandates to grow the shipping book. The offshore, cruise and gas (LNG) sectors were mentioned as sectors that meet the banks credit and return expectations. The panel see consolidation among shipping companies as a feature in 2013, and although some banks are growing their books, the overall effect will be less credit available to a smaller group of clients. These clients can be shipping companies with financial investors. Banks will always consider the same factors;

  • The management, financial, commercial and technical.
  • The business plan
  • The initial capital structure
  • The mix of employment on the vessels

?The client profile today would be corporate and could include capital private equity with the banks having comfort from recourse to a corporate balance sheet with protection of covenants. There would also have to cross sell to other products within the bank, so that the bank is optimising its use of its capital, which is now a scarce resource. Banks would also like to see evidence of long term commitment to shipping. A typical market clearing transaction today would be:

  • 65-70% financing
  • 15 year profile
  • 5-7 year tenor
  • Pricing at plus or minus 300 bps
  • Upfront fees 1-1.25%
  • Plus the usual covenants.

Mr Ryland of DNB pointed at that LTVs today are checked dynamically every six months to test the banks security, and not historically every twelve months as in the past.

?There was a very interesting question from Richard Greiner of the shipping accountants Moore Stephens. ?What is your position about actually having ships on your balance sheet??

Mr Anton said ?Standard Chartered does own ships, we have a leasing division.??The panel said that generally the banks don?t want to own ships on the balance sheet. In the short term banks will warehouse troubled ships with friendly clients or convert loans into leasing deals, and so avoiding taking ships on the balance sheet.?Mr Greiner pointed out that the auditors are beginning to scrutinise the warehousing solution and these ships will be treated as being on the balance sheet.

Like this:

Be the first to like this.

Source: http://shippingresearch.wordpress.com/2013/01/31/how-do-banks-deal-with-problem-loans-marine-money-ship-finance-london-jan-2013-part-2/

rihanna and chris brown affirmative action helicon zac efron and taylor swift real housewives of orange county bloom energy franklin graham

RIM Just Changed It's Name To BlackBerry - Business Insider

Kevin Smith/Business Insider

?

From this point on, RIM will now go by the name BlackBerry,?BlackBerry CEO Thorsten Heins announced today.

Heins explained that the company is changing its name in order to maintain one brand and one promise.?

Its new stock ticker will be BBRY, rather than RIMM.

Source: http://www.businessinsider.com/rim-just-changed-its-name-to-blackberry-2013-1

invisible children kony 2012 space weather sunspots pac 12 tournament sun storm tri international criminal court

A Map Of NFL Team Allegiance

Facebook data shows exactly where the fans are.


We've posted visualizations from Facebook's Data Science Team before, but I think it's safe to say that their newest effort--a county-level map of NFL fandom across the U.S.--is their most admirable yet. Based on the team page Likes and locations of over 35 million account holders, it's probably the most accurate, precise geography of sports fandom ever.

Deadspin has a nice run-down of the take-aways, to which I would add only one question: Does anyone know what that blob of Steelers fans is doing in southern Oregon?

Click here to see a larger version of the map.

[via Deadspin]

Source: http://www.popsci.com/science/article/2013-01/map-nfl-team-allegiance

marist south carolina primary results betty white ed reed football schedule jo paterno dead south carolina